Luciana B. Ferreira

Seropedica, RJ 23897000, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib.

Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib.

Journal: Biomedicines

Published: February 02, 2026

Osteopontin-c gene expression and subcellular localization in ovarian cancer cells: Implications for prognosis and therapeutic responses.

Osteopontin-c gene expression and subcellular localization in ovarian cancer cells: Implications for prognosis and therapeutic responses.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 23, 2025

Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer.

Overexpression of Osteopontin-a and Osteopontin-c Splice Variants Are Worse Prognostic Features in Colorectal Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: August 06, 2024

Expression and prognostic potential of osteopontin splice variants in malignant melanoma.

Expression and prognostic potential of osteopontin splice variants in malignant melanoma.

Journal: Clinical and translational science

Published: June 28, 2024

The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles.

The Intracellular and Secreted Sides of Osteopontin and Their Putative Physiopathological Roles.

Journal: International journal of molecular sciences

Published: December 16, 2022

Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms.

Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms.

Journal: Biomedicines

Published: August 18, 2021

Molecular Aspects of Thyroid Calcification.

Molecular Aspects of Thyroid Calcification.

Journal: International journal of molecular sciences

Published: October 01, 2020

Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines.

Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines.

Journal: Molecular biology reports

Published: May 11, 2020

Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.

Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.

Journal: Oncology reports

Published: May 06, 2020

Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1".

Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1".

Journal: Leukemia research

Published: September 21, 2019

The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer.

The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer.

Journal: Oncotarget

Published: July 18, 2019

OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines.

OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines.

Journal: International journal of molecular sciences

Published: August 29, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026